» Articles » PMID: 22322557

Reactivation of Latent HIV-1 by a Wide Variety of Butyric Acid-producing Bacteria

Overview
Publisher Springer
Specialty Biology
Date 2012 Feb 11
PMID 22322557
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Latently infected cells harbor human immunodeficiency virus type 1 (HIV-1) proviral DNA copies integrated in heterochromatin, allowing persistence of transcriptionally silent proviruses. It is widely accepted that hypoacetylation of histone proteins by histone deacetylases (HDACs) is involved in maintaining the HIV-1 latency by repressing viral transcription. HIV-1 replication can be induced from latently infected cells by environmental factors, such as inflammation and co-infection with other microbes. It is known that a bacterial metabolite butyric acid inhibits catalytic action of HDAC and induces transcription of silenced genes including HIV-1 provirus. There are a number of such bacteria in gut, vaginal, and oral cavities that produce butyric acid during their anaerobic glycolysis. Since these organs are known to be the major site of HIV-1 transmission and its replication, we explored a possibility that explosive viral replication in these organs could be ascribable to butyric acid produced from anaerobic resident bacteria. In this study, we demonstrate that the culture supernatant of various bacteria producing butyric acid could greatly reactivate the latently-infected HIV-1. These bacteria include Fusobacterium nucleatum (commonly present in oral cavity, and gut), Clostridium cochlearium, Eubacterium multiforme (gut), and Anaerococcus tetradius (vagina). We also clarified that butyric acid in these culture supernatants could induce histone acetylation and HIV-1 replication by inhibiting HDAC. Our observations indicate that butyric acid-producing bacteria could be involved in AIDS progression by reactivating the latent HIV provirus and, subsequently, by eliminating such bacterial infection may contribute to the prevention of the AIDS development and transmission.

Citing Articles

Expanding the human gut microbiome atlas of Africa.

Maghini D, Oduaran O, Olubayo L, Cook J, Smyth N, Mathema T Nature. 2025; 638(8051):718-728.

PMID: 39880958 PMC: 11839480. DOI: 10.1038/s41586-024-08485-8.


A gut check: understanding the interplay of the gastrointestinal microbiome and the developing immune system towards the goal of pediatric HIV remission.

Soo N, Farinre O, Chahroudi A, Boliar S, Goswami R Retrovirology. 2024; 21(1):15.

PMID: 39425183 PMC: 11490017. DOI: 10.1186/s12977-024-00648-9.


A Two-Faced Gut Microbiome: Butyrogenic and Proinflammatory Bacteria Predominate in the Intestinal Milieu of People Living with HIV from Western Mexico.

Baltazar-Diaz T, Andrade-Villanueva J, Sanchez-Alvarez P, Amador-Lara F, Holguin-Aguirre T, Sanchez-Reyes K Int J Mol Sci. 2024; 25(9).

PMID: 38732048 PMC: 11084381. DOI: 10.3390/ijms25094830.


The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).

Goncalves-Nobre J, Matos A, Carreira M, Santos A, Veiga L, Ginete C Front Cell Infect Microbiol. 2024; 13:1251913.

PMID: 38532749 PMC: 10963500. DOI: 10.3389/fcimb.2023.1251913.


The essential role of intestinal microbiota in cytomegalovirus reactivation.

Kohda C, Ino S, Ishikawa H, Kuno Y, Nagashima R, Iyoda M Microbiol Spectr. 2023; :e0234123.

PMID: 37754566 PMC: 10581228. DOI: 10.1128/spectrum.02341-23.


References
1.
Niederman R, Lu B, Robinson P, Naleway C . Short-chain carboxylic acid concentration in human gingival crevicular fluid. J Dent Res. 1997; 76(1):575-9. DOI: 10.1177/00220345970760010801. View

2.
Colin L, Van Lint C . Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology. 2009; 6:111. PMC: 2797771. DOI: 10.1186/1742-4690-6-111. View

3.
Mbopi-Keou F, Belec L, Teo C, Scully C, Porter S . Synergism between HIV and other viruses in the mouth. Lancet Infect Dis. 2002; 2(7):416-24. DOI: 10.1016/s1473-3099(02)00317-1. View

4.
Mortensen P, Clausen M . Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996; 216:132-48. DOI: 10.3109/00365529609094568. View

5.
Imai K, Okamoto T . Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem. 2006; 281(18):12495-505. DOI: 10.1074/jbc.M511773200. View